Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study
Crossref DOI link: https://doi.org/10.1007/s00280-015-2881-x
Published Online: 2015-10-19
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Young Saing
Sym, Sun Jin
Baek, Min Young
Park, Inkeun
Hong, Junshik
Ahn, Hee Kyung
Park, Jinny
Cho, Eun Kyung
Lee, Woon Ki
Chung, Min
Kim, Hyung-Sik
Lee, Jae Hoon
Shin, Dong Bok
Text and Data Mining valid from 2015-10-19